Moody Aldrich Partners LLC Iovance Biotherapeutics, Inc. Transaction History

Moody Aldrich Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$7.59 - $17.47 $1.71 Million - $3.93 Million	224,831 New	224,831 $3.33 Million
Q1 2021 May 10, 2021	SELL	$28.67 - $52.59 $2.9 Million - $5.32 Million	-101,161 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $994,130 - $1.78 Million	35,454 Added 53.96%	101,161 $4.69 Million
Q3 2020 Nov 12, 2020	BUY	$27.75 - $36.3 $26,418 - $34,557	952 Added 1.47%	65,707 $2.16 Million
Q2 2020 Jul 30, 2020	SELL	$27.21 - $41.0 $545,016 - $821,230	-20,030 Reduced 23.62%	64,755 $1.78 Million
Q1 2020 May 07, 2020	SELL	$19.54 - $38.85 $1,739 - $3,457	-89 Reduced 0.1%	84,785 $2.54 Million
Q4 2019 Feb 07, 2020	BUY	$17.95 - $29.41 $23,532 - $38,556	1,311 Added 1.57%	84,874 $2.35 Million
Q3 2019 Nov 12, 2019	SELL	$17.99 - $26.0 $15,147 - $21,892	-842 Reduced 1.0%	83,563 $1.52 Million
Q2 2019 Jul 26, 2019	BUY	$9.78 - $24.52 $825,480 - $2.07 Million	84,405 New	84,405 $2.07 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.